• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[科林法尔抗心绞痛作用的机制]

[Mechanisms of the anti-anginal effect of korinfar].

作者信息

Voronkov L G, Sokolov N F

出版信息

Farmakol Toksikol. 1988 Sep-Oct;51(5):38-41.

PMID:3208884
Abstract

Some clinical, hemodynamic and biochemical parameters were studied in 25 patients with ischemic heart disease of II-III functional classes depending on the presence of the antianginal effect during paired loading pharmacodynamic tests with corinfar. The antianginal effect of corinfar was found to be associated with a marked growth of "double product" and the presence of a clinical symptom of adaptation. In patients with the lack of corinfar antianginal effect there were noted the adaptation symptom absence and a higher blood catecholamine level. A decrease of the postloading did not correlate with the drug antianginal effect. The data could indicate that in the mechanism of corinfar antianginal effect the determining factor is its direct influence on the coronary circulation.

摘要

对25例II - III级功能类别的缺血性心脏病患者,根据在使用可立泛进行配对负荷药效学试验期间是否存在抗心绞痛作用,研究了一些临床、血流动力学和生化参数。发现可立泛的抗心绞痛作用与“双乘积”的显著增加以及适应的临床症状的存在有关。在缺乏可立泛抗心绞痛作用的患者中,未观察到适应症状且血儿茶酚胺水平较高。负荷后降低与药物抗心绞痛作用无关。这些数据可能表明,在可立泛抗心绞痛作用机制中,决定因素是其对冠脉循环的直接影响。

相似文献

1
[Mechanisms of the anti-anginal effect of korinfar].[科林法尔抗心绞痛作用的机制]
Farmakol Toksikol. 1988 Sep-Oct;51(5):38-41.
2
[The efficacy of the long-term therapy of patients with stable stenocardia using korinfar and finoptin].
Vrach Delo. 1989 Jul(7):67-9.
3
[Mechanism of the anti-anginal action of korinfar].[科林法尔抗心绞痛作用的机制]
Farmakol Toksikol. 1986 Sep-Oct;49(5):90-2.
4
[The use of metoprolol with calcium antagonists of different mechanisms of action (diltiazem and nifedipine) in patients with stenocardia of effort].
Ter Arkh. 1990;62(1):32-6.
5
[Correlation between the therapeutic effectiveness of corinfar and its dose in patients with exercise-induced stenocardia].[可力多治疗运动诱发型心绞痛的疗效与其剂量的相关性]
Ter Arkh. 1986;58(5):77-81.
6
[A comparative evaluation of the antianginal efficacy of aldizem and korinfar in patients with stable stenocardia].[阿地洛尔与可立夫在稳定型心绞痛患者中抗心绞痛疗效的比较评估]
Ter Arkh. 1991;63(8):50-2.
7
[Comparative pharmacodynamics study of korinfar and isoptin in ischemic heart disease].[科力法与异搏定在缺血性心脏病中的比较药效学研究]
Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR. 1981;4(1):64-70.
8
[Action of nifedipine on effort tolerance and on the left ventricular function during exercise in patients suffering from angina pectoris (author's transl)].硝苯地平对心绞痛患者运动耐力及运动期间左心室功能的作用(作者译)
G Ital Cardiol. 1980;10(4):431-9.
9
[Effect of corinfar on the course of angina pectoris and indices of carbohydrate metabolism in relation to the type of glucose tolerance].[可立爽对心绞痛病程及与糖耐量类型相关的碳水化合物代谢指标的影响]
Ter Arkh. 1987;59(11):35-8.
10
[The clinical pharmacology and efficacy of the new Soviet calcium antagonist foridon].[苏联新型钙拮抗剂福立顿的临床药理学与疗效]
Ter Arkh. 1990;62(10):138-42.